Insider Trading Alert - KTEC, TRC And MDRX Traded By Insiders

Yesterday, April 8, 2016, 32 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $800.00 to $1,875,022.50.

Highlighted Stocks Traded by Insiders:

Key Technology (KTEC) - FREE Research Report

PVAM Perlus Microcap Fund, L.P., who is 10% Owner at Key Technology, bought 8,171 shares at $7.40 on April 8, 2016. Following this transaction, the 10% Owner owned 692,523 shares meaning that the stake was boosted by 1.19% with the 8,171-share transaction.

The shares most recently traded at $7.25, down $0.15, or 2.13% since the insider transaction. Historical insider transactions for Key Technology go as follows:

  • 4-Week # shares bought: 8,348
  • 4-Week # shares sold: 1,000
  • 12-Week # shares bought: 8,348
  • 12-Week # shares sold: 1,000
  • 24-Week # shares bought: 127,227
  • 24-Week # shares sold: 1,000

The average volume for Key Technology has been 13,200 shares per day over the past 30 days. Key Technology has a market cap of $43.7 million and is part of the industrial goods sector and industrial industry. Shares are down 28.74% year-to-date as of the close of trading on Wednesday.

Key Technology, Inc., together with its subsidiaries, designs, manufactures, sells, and services process automation systems integrating electro-optical inspection, sorting, and process systems in the United States and internationally. Currently, there are no analysts who rate Key Technology a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KTEC - FREE

TheStreet Quant Ratings rates Key Technology as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, poor profit margins and generally disappointing historical performance in the stock itself. Get the full Key Technology Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Tejon Ranch (TRC) - FREE Research Report

Bielli Gregory S., who is President/ CEO at Tejon Ranch, bought 1,000 shares at $20.02 on April 8, 2016. Following this transaction, the President/ CEO owned 19,486 shares meaning that the stake was boosted by 5.41% with the 1,000-share transaction.

The shares most recently traded at $19.78, down $0.24, or 1.21% since the insider transaction. Historical insider transactions for Tejon Ranch go as follows:

  • 4-Week # shares bought: 12,430
  • 4-Week # shares sold: 20,000
  • 12-Week # shares bought: 20,000
  • 12-Week # shares sold: 20,000
  • 24-Week # shares bought: 132,318
  • 24-Week # shares sold: 20,000

The average volume for Tejon Ranch has been 37,200 shares per day over the past 30 days. Tejon Ranch has a market cap of $422.8 million and is part of the financial sector and real estate industry. Shares are up 8.77% year-to-date as of the close of trading on Wednesday.

Tejon Ranch Co. operates as a diversified real estate development and agribusiness company. The company operates through five segments: Commercial/Industrial Real Estate Development, Resort/Residential Real Estate Development, Mineral Resources, Farming, and Ranch Operations. The company has a P/E ratio of 145.9. Currently, there are no analysts who rate Tejon Ranch a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TRC - FREE

TheStreet Quant Ratings rates Tejon Ranch as a sell. The company's weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself, feeble growth in its earnings per share and disappointing return on equity. Get the full Tejon Ranch Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Allscripts Healthcare Solutions (MDRX) - FREE Research Report

Olis Dennis, who is SVP of Operations at Allscripts Healthcare Solutions, sold 25,000 shares at $14.00 on April 8, 2016. Following this transaction, the SVP of Operations owned 217,887 shares meaning that the stake was reduced by 10.29% with the 25,000-share transaction.

The shares most recently traded at $13.84, down $0.16, or 1.16% since the insider transaction. Historical insider transactions for Allscripts Healthcare Solutions go as follows:

  • 4-Week # shares bought: 6,500
  • 4-Week # shares sold: 37,500
  • 12-Week # shares bought: 6,500
  • 12-Week # shares sold: 37,500
  • 24-Week # shares bought: 6,500
  • 24-Week # shares sold: 37,500

The average volume for Allscripts Healthcare Solutions has been 2.9 million shares per day over the past 30 days. Allscripts Healthcare Solutions has a market cap of $2.6 billion and is part of the technology sector and computer software & services industry. Shares are down 9.33% year-to-date as of the close of trading on Wednesday.

Allscripts Healthcare Solutions, Inc. provides information technology and services to healthcare organizations in the United States, Canada, and internationally. Currently, there are 11 analysts who rate Allscripts Healthcare Solutions a buy, no analysts rate it a sell, and 11 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MDRX - FREE

TheStreet Quant Ratings rates Allscripts Healthcare Solutions as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full Allscripts Healthcare Solutions Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Even Standing Desk Company Varidesk Is Watching How the Trump Tariffs Play Out

Even Standing Desk Company Varidesk Is Watching How the Trump Tariffs Play Out

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

Schlumberger Stock Dips as Investors Ignore Start of 'Earnings Liftoff'

Schlumberger Stock Dips as Investors Ignore Start of 'Earnings Liftoff'

GSK Shares Climb as Board Is Said to Mull Breakup of Pharma Giant

GSK Shares Climb as Board Is Said to Mull Breakup of Pharma Giant

Stocks End Close to Home

Stocks End Close to Home